Solutions for Life Sciences
Trusted oncology evidence built for life sciences
In a fast-changing global oncology landscape with new regulations, evolving treatments, and shifting standards of care, you need a strategic partner who turns evidence into confident decisions.
Not all evidence is created equal
5M+
patient records
4
largest cancer geographies
2,000+
peer-reviewed publications powered by Flatiron data
45+
global regulatory decisions informed
20+
publications validating our real-world endpoints
Not all evidence is created equal
Flatiron’s real-world evidence (RWE) brings together high-fidelity, global real-world data, deep oncology expertise, and AI-powered intelligence to help you maximize success across the drug development lifecycle.
BY THE NUMBERS
5M+
patient records
4
largest cancer geographies
2000+
peer-reviewed publications powered by Flatiron data
45+
global regulatory decisions informed
20+
publications validating our real-world endpoints
100%
of the top 20 oncology life sciences companies partner with Flatiron
We partner with life sciences teams across the drug development lifecycle
-
Natural history and unmet needs
-
Biomarker testing strategy
-
Target Product Profile (TPP) design
-
Trial design and protocol optimization
-
Predictive modeling and digital twins
-
Treatment patterns and survival
-
Cost and resource utilization
-
Natural history and burden of illness
-
Comparative effectiveness
-
Indirect treatment comparisons
-
Clinical decision making analysis
-
Natural history and burden of illness
-
Comparative effectiveness
-
Post-marketing commitments and requirements
-
International transportability
-
HTA submission
-
Risk analysis
-
Fit-for-purpose assessment
-
Response to information request
-
Briefing book composition
-
Health Authority meeting prep and attendance
-
Size market opportunities
-
Launch and market performance
-
HCP segmentation and engagement
-
Prescribing patterns and physician sentiment
Explore our solutions for life sciences organizations
High-quality, global data that reflects how oncology care is actually delivered in the real world
Advanced analytics, expertise tooling built on top of Flatiron RWD to uncover actionable insights across the development lifecycle
Flatiron’s AI-powered platform that uses intuitive natural language to unlock Flatiron’s datasets, transforming complex data into actionable insights with ease
Deep oncology expertise
Oncologists, research scientists, data engineers, health equity analysts, regulatory experts: An integrated team of in-house specialists stands ready to jump in to meet your needs, whether you’re shaping your company’s portfolio strategy or defending post-market decisions. From one end of the drug development lifecycle to the other, think of us as an extension of your own team.
